Akèy › Lukemi lenfositè kwonik › Oregon › Eugene
Etid klinik pou Lukemi lenfositè kwonik nan Eugene, OR
6 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan ak bò kote Eugene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Ap rekriteFaz 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Ap rekriteFaz 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Ap rekriteFaz 3
- Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Ap rekriteFaz 1/2
- Oncology Associates of Oregon, Eugene
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ap rekriteFaz 2
- Williamette Valley Cancer Institute & Research Center, Eugene
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Ap rekriteFaz 3
- Willamette Valley Cancer Institute and Research Center /ID# 266326, Eugene
Etid Lukemi lenfositè kwonik nan lòt vil
- Boston, MA31 etid
- Columbus, OH28 etid
- Durham, NC27 etid
- Washington, DC22 etid
- Seattle, WA20 etid
- Rochester, MN19 etid
- New York City, NY18 etid
- Houston, TX17 etid
- Baldwin Park, CA16 etid
- Milwaukee, WI15 etid
- Cincinnati, OH14 etid
- Chicago, IL14 etid
Lòt etid nan Eugene
- Kansè Poumon ki pa ti selil13 etid
- Kansè ovè9 etid
- Kansè Endomèt8 etid
- Kansè nan tete7 etid
- Myelom Miltip6 etid
- Kansè Metastatik6 etid
- Kansè (tout kalite)6 etid
- Itilizasyon Dwòg ak Depandans5 etid
- Kansè poumon5 etid
- Degeneresans makile5 etid
- Obèsite4 etid
- Kansè pwostat3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.